CLL1 polymeric nanoparticles loaded with PI3K/BRD4 dual inhibitor MDP5 and azacitidine as a novel treatment for TP53 mutated acute myeloid leukemia

International Journal of Pharmaceutics 2026

View at publisher

Authors: Qiaoyu Pan, Fei Yang, Ajaykumar Chittipolu, Raghu Ramanathan, Yuxiang Dong, R. Katherine Hyde, Vijaya Raj Bhatt, Ram I. Mahato

DOI: 10.1016/j.ijpharm.2026.126832

Cited by: 1

References: 34

Fields of Study & Subjects

Acute Myeloid Leukemia Research Protein Degradation and Inhibitors Chronic Lymphocytic Leukemia Research

References 34